BofA Securities Adjusts Price Target on BrightSpring Health Services to $16.50 From $14, Maintains Buy Rating
BTIG Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
BrightSpring Health Svcs Is Maintained at Buy by Guggenheim
BrightSpring Health Analyst Ratings
Guggenheim Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $18
Wells Fargo Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $17
Buy Rating Affirmed for BrightSpring Health Services Amidst Strategic Share Transaction and Strong Operational Performance
Jefferies Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $18.5
Analysts Are Bullish on Top NA Stocks: BrightSpring Health Services, Inc. (BTSG), American Healthcare REIT, Inc. (AHR)
Analysts Have Conflicting Sentiments on These NA Companies: Nuveen Churchill Direct Lending Corp. (NCDL), Ibotta, Inc. Class A (IBTA) and BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Analyst Ratings
Analysts Offer Insights on NA Companies: BrightSpring Health Services, Inc. (BTSG), Reddit Inc Class A (RDDT) and American Healthcare REIT, Inc. (AHR)
Morgan Stanley Sticks to Its Buy Rating for BrightSpring Health Services, Inc. (BTSG)
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $18
BrightSpring Health Services: Strong Growth and Margin Improvement Justify Buy Rating
Wells Fargo Sticks to Their Buy Rating for BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Analyst Ratings
Key Takeaways From BrightSpring Health Analyst Ratings
BrightSpring Health Analyst Ratings
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16